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S UMMA R Y
OB J E C T I V E : To investigate the association between
patients’ social risk factors and the risk of tuberculous
infection and TB disease among their contacts in England.
DE S I GN : This was a cohort study of all TB cases from
North West England diagnosed between 27 March 2012
and 28 June 2016. The social risk factors of TB cases
were evaluated to estimate their need for enhanced case
management (ECM), from 0 (standard of care) to 3
(intensive social support).
R E SU LT S : A total of 2139 cases and their 10 019
contacts met the eligibility criteria. Being a contact of
a patient with smear-positive TB with high ECM or
being of Black Caribbean ethnicity was independently
associated with greater odds of active TB disease (smear-
positive vs. smear-negative, OR 5.3, 95%CI 3.2–8.7;
ECM-3 vs. ECM-0, OR 2.2, 95%CI 1.01–5.0; Black
Caribbean vs. White, OR 7.4, 95%CI 2.1–25). Being a
contact of a patient with smear-positive TB or of Black
Caribbean ethnicity was also independently associated
with greater odds of tuberculous infection (smear-
positive vs. smear-negative, OR 5.3, 95%CI 3.8–7.3;
and Black Caribbean vs. White, OR 6.7, 95%CI 2.0–
25).
CONC LU S I ON S : The social complexity and ethnicity of
patients were associated with tuberculous infection and
TB disease in their contacts.
K E Y WORD S : TB; contact screening; TB prevention;
TB control; enhanced case management; social and
clinical complexity; public health
DESPITE DECLINING TUBERCULOSIS (TB) rates
in England,1,2 there has been an increase in the
proportion of TB cases with complex clinical and
social needs.2 Identifying cases and their household
contacts, and providing enhanced TB care where
appropriate, are key components of the Public Health
England and National Health Service England
Collaborative Tuberculosis Strategy 2015–2020.2
Evaluating clinical and social needs by assessment
of the enhanced case management (ECM) level is one
method of identifying high-risk TB cases.3
In North West England, TB specialist nurses
evaluate the clinical and social needs of TB patients
and assign an ECM level from 0 (standard case
management) to 3 (complex needs requiring the
highest level of intensive support), which is subse-
quently reassessed during multidisciplinary TB cohort
review (known as TB cohort audit [TBCA] in North
West England).4 The ECM offered varies according to
the needs of each household, but can include intensive
support from ancillary services and partner organi-
sations, more frequent clinic or home visits, and
transport vouchers or translation services to over-
come language barriers. Table 1 provides a summary
of the guide to the classification of patients to ECM
levels used in TB cohort reviews. As a general rule, a
patient’s overall ECM level will be classified accord-
ing to his/her highest level of need across three
domains: clinical factors, TB-specific factors and
social factors (Table 1). For example, if a patient’s
social factors are scored as ECM level 3 and his/her
clinical and TB-specific factors are scored as ECM
level 2, the patient’s overall ECM level will be 3.
Close contacts of TB patients are known to have an
increased risk of prevalent latent tuberculous infection
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(LTBI) and active TB disease.1 Contact tracing and
preventive therapy are well-established, important
tools in TB prevention, particularly for underserved
households in which patients and contacts share
similar social and/or clinical risk factors.5 However,
there is minimal evidence concerning whether patients’
social or clinical risk factors, including ECM level and
ethnicity, can predict rates of prevalent LTBI and active
TB disease in their household contacts. We aimed to
fill this knowledge gap.
METHODS
Study design
A retrospective cohort study in North West England.
Data source
Patient data were collected using Public Health
England’s national Enhanced TB Surveillance (ETS)
system and supplemented by complementary North
West TBCA data. Neither ETS nor TBCA contains
individual-level data about patients’ contacts. The
contact data entered into ETS include the total number
of contacts identified per patient and, among these, the
number of contacts who were screened for LTBI or
active TB disease, diagnosed with LTBI or active TB
disease, started on preventive therapy for LTBI, and
those who completed preventive therapy for LTBI.
Data were not available concerning the treatment or
treatment outcomes of contacts diagnosed with active
TB disease, or the contact screening and LTBI
diagnostic methods used (e.g., symptom screening,
chest radiograph, microbiological testing of sputum
samples, the tuberculin skin test and interferon-gamma
release assay).
Eligibility
Participants were TB cases of any age from North
West England with microbiologically or clinically
confirmed pulmonary or extra-pulmonary TB disease
notified to ETS between 27 March 2012 and 28 June
2016, with a defined ECM level, and at least one
identified contact.
Outcomes
The primary outcome was the prevalence of LTBI or
of active TB disease and a positive screening outcome
(sum of LTBI and active TB disease) in the contacts of
Table 1 Guide to classification of patients to ECM levels used in the TB Cohort Review4
ECM Clinical factors TB-specific Social factors
0 Physically able to self-medicate
No CNS impairment
Positive IsoScreen* at reviews
Correct tablet count at reviews
Contact tracing requirements limited
to adults in the same household
No stigma-related issues
No language barriers
No housing or finance issues impacting on
treatment
1 Elderly requiring monitoring for side
effects
Children requiring monitoring to ensure
compliance of child and parent/carer
Requires GP or community pharmacy input
for blister packs to check correct doses
Taking complex medications e.g., HIV
medications
Disease site e.g., smear-positive pulmonary
or central nervous system disease
Contact tracing requirements in
various areas and/or settings e.g.,
patient out of area, workplace,
community group settings
Stigma that can be dealt with through
one-to-one education
Requires interpreter for first visit but has
some understanding of English
Requires signposting for benefits and/or
financial issues
Patient difficult to reach, e.g., no front
door bell, more than one address,
problems getting time off work/college,
refusal of home visits
2 Having complex side effects requiring LFT
monitoring
Needs more regular prompting with
medications, e.g., blister packs, regular
IsoScreen testing, tablet counts
HIV and TB co-infection and starting both
antiretroviral and anti-tuberculosis
medications at a similar time
Single drug resistance
Transmission within contacts or
children who are contacts
Stigma that requires more formal
education, e.g., through community
centres or workplaces
Financial difficulties that may affect
treatment compliance, e.g., attending
clinic, poor nutrition, poor heating
Language barriers throughout treatment
requiring easily accessible interpreter at
each visit either face to face or by phone
Alcohol and/or drug dependency without
LFT derangement
Patient difficult to reach, e.g., do not
attend clinics, not home for reviews
3 More than one drug resistance
Needs reintroduction of medications, e.g.,
due to deranged LFTs
Complex contact tracing, e.g.,
transmission to children, vulnerable
groups, extensive transmission
Involvement of PHE for workplace or
community screening
Difficult language barriers throughout
treatment
Homelessness or housing issues due to
finance
Illegal immigrants, difficulty accessing
benefits
Potentially dangerous patients, where
more than one person is required to visit
Children who do not attend, and where
social service input is required
Patient difficult to reach, e.g., consistent
failure to attend at clinics, consistently
not home for reviews
*Urine test used to detect isoniazid for assessing patient adherence to anti-tuberculosis treatment. ECM¼enhanced case management; TB¼ tuberculosis; CNS¼
central nervous system; GP¼ general practitioner; HIV¼ human immunodeficiency virus; LFT¼ liver function test; PHE¼ Public Health England.
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patients as entered into the ETS database. The
secondary outcome was identification of the specific
social and clinical risk factors of patients who were
independently associated with LTBI and active TB
disease in their contacts.
Analysis
For the primary outcome, prevalence of LTBI or of
active TB disease and a positive screening outcome in
contacts were calculated and compared across their
index patients’ ECM levels using the v2 test for trend
and between each ECM level using the v2 test. The
number of contacts needed to screen (NNS) to detect
one case of LTBI or active TB disease, or a positive
screening outcome was also calculated.
For the secondary outcome, we used a multivari-
able logistic regression model to estimate odds ratios
adjusted for potential confounders of contacts’ LTBI
and active TB disease prevalence according to their
index patient’s social and clinical risk factors (sex,
age, ECM level, ethnicity, sputum smear positivity
and postcode-associated index of multiple depriva-
tion score).
Statistical analyses were performed using Stata v 12
(StataCorp, College Station, TX, USA) and R v 3.5.0
(R Foundation for Statistical Computing, Vienna,
Austria).
Ethics
As anonymised, routinely collected public health
surveillance data were used, participant consent was
not sought. This study is part of wider evaluations
approved by the UK North West TB Cohort Audit
Steering Group, which reports to the UK North West
TB Control Board.
RESULTS
During the study period, 2139 TB cases met eligibility
criteria, and had 10 019 household contacts screened
(median 4, interquartile range [IQR] 2–6, range 1–
24). Of 2139 TB cases, 949 (44%) were categorised
as ECM-0, 660 (31%) as ECM-1, 303 (14%) as
ECM-2 and 227 (11%) as ECM-3. Patients with
higher ECM levels were more likely to: have smear-
positive pulmonary TB, be White and UK-born, be
unemployed, and have more contacts identified per
patient (Table 2). The most prevalent social and
clinical risk factors contributing to higher ECM levels
were being clinically complex, having a language
barrier and being considered at risk of poor adher-
ence to TB medications (Table 2). Contacts of
patients with higher ECM levels were less likely to
complete preventive therapy once initiated (Table 2).
Compared with the contacts of ECM-0 patients,
contacts of patients with higher ECM levels were
significantly more likely to have prevalent active TB
disease (ECM-3: 4.2%, 95%CI 2.4–6.0 vs. ECM-0:
1.1%, 95%CI 0.1–1.16, P , 0.001 test for trend),
LTBI (ECM-3: 10%, 95%CI 7.0–13 vs. ECM-0:
5.7%, 95%CI 4.6–6.8; P , 0.001) and a positive
screening outcome (ECM-3: 14%, 95%CI 10–17 vs.
Figure 1 Association of patients’ (n ¼ 2139) ECM level with LTBI or active TB disease and positive screening outcomes in their
contacts. P values represent v2 test for trend across ECM levels, which was P, 0.001 for LTBI, active TB disease and positive screening
outcome respectively. Error bars are the 95%CIs for the proportion of contacts with positive screening outcome across ECM levels. A
sensitivity analysis was performed excluding patients in whom ECM levels were calculated on the basis of poor adherence or having
child contacts. Proportions of assessed contacts with LTBI in the sensitivity analysis were as follows: total (n¼860) 5.9% (95%CI 4.5–
7.2); ECM 0 (n¼391) 6.3% (95%CI 4.2–8.4); ECM 1 (n¼255) 6.5% (95%CI 3.8–9.1); ECM 2 (n¼132) 3.3% (95%CI 1.1–5.6); ECM
3 (n¼82) 6.0% (95%CI 1.8–10); P¼0.9. Proportions of assessed contacts with active TB disease in the sensitivity analysis were: total
(n¼860) 1.4% (95%CI 0.70–2.1); ECM 0 (n¼391) 1.1% (95%CI 0.11–2.0); ECM 1 (n¼255) 0.78% (95%CI 0.0–1.7); ECM 2 (n¼
132) 2.4% (95%CI 1.6–4.7); ECM 3 (n¼82) 3.3% (95%CI 0.0–6.4); P¼0.003. ECM¼enhanced case management; CI¼confidence
interval; NNS¼ number needed to screen; TB¼ tuberculosis; LTBI¼ latent tuberculous infection.
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Table 2 Patients’ sociodemographic features and their contacts’ outcomes according to ECM level
Total
n (%)
ECM 0
n (%)
ECM 1
n (%)
ECM 2
n (%)
ECM 3
n (%) P value*
Patients 2 139 (100) 949 (44) 660 (31) 303 (14) 227 (11) —
Age group, years
0–15 69 (3) 21 (2) 26 (4) 16 (5) 6 (3) 0.1
16–30 495 (23) 236 (25) 135 (20.5) 77 (25.5) 47 (21)
31–45 683 (32) 327 (35) 200 (30) 85 (28) 71 (31)
46–65 533 (25) 228 (24) 171 (26) 68 (22.5) 66 (29)
.65 359 (17) 137 (14) 128 (19.5) 57 (19) 37 (16)
Sex 0.2
Male 1 199 (56) 516 (54) 381 (58) 169 (56) 133 (59)
Female 940 (44) 433 (46) 279 (42) 134 (44) 94 (41)
Site of TB disease ,0.001
Extra-pulmonary 1 077 (50) 544 (58) 310 (47) 137 (45) 76 (33)
Pulmonary, smear 598 (28) 256 (27) 195 (30) 90 (30) 57 (25)
Pulmonary, smearþ 464 (22) 139 (15) 155 (23) 76 (25) 94 (41)
Ethnic group (n ¼ 2083) ,0.001†
White 559 (27) 206 (22.5) 165 (26) 82 (27.5) 106 (47)
Black, African 241 (11.5) 100 (11) 90 (14) 30 (10) 21 (9)
Black, Caribbean 11 (0.5) 5 (0.5) 1 (0.5) 2 (0.5) 3 (1)
Black, Other 8 (0.5) 4 (0.5) 3 (0.5) 1 (0.5) 0 (0)
Chinese 34 (2) 11 (1) 16 (2) 5 (1.5) 2 (1)
Indian 338 (16) 188 (20.5) 69 (11) 60 (20) 21 (9)
Bangladeshi 54 (2.5) 25 (3) 20 (3) 5 (2.5) 4 (2)
Pakistani 711 (34) 325 (35) 242 (38) 93 (31) 51 (23)
Mixed/Other 127 (6) 57 (6) 33 (5) 20 (6.5) 17 (8)
UK-born (n ¼ 2081) ,0.001
Yes 700 (34) 262 (28) 218 (34) 107 (36) 113 (51)
No 1 381 (66) 660 (72) 422 (66) 192 (64) 107 (49)
Time in UK, years,
median [IQR] (n ¼ 1288)
8 [3–20] 8 [4–16] 9 [3–23] 7.5 [2–22] 10 [2–21]
Poverty level (n ¼ 2113) 0.3
1 (most poor) 1 305 (62) 579 (62) 411 (63) 183 (62) 132 (59)
2 356 (17) 162 (17) 115 (18) 47 (16) 32 (14)
3 203 (9.5) 90 (9.5) 53 (8) 30 (10) 30 (13.5)
4 141 (6.5) 65 (7) 45 (7) 20 (6.5) 11 (5)
5 (least poor) 108 (5) 43 (4.5) 29 (4) 17 (5.5) 19 (8.5)
Employment ,0.001
Employed 1 882 (88) 863 (91) 591 (90) 266 (88) 162 (71)
Unemployed 257 (12) 86 (9) 69 (10) 37 (12) 65 (29)
ECM factor ,0.001‡
Alcohol use 64 (3.0) 6 (0.63) 13 (2.0) 8 (2.6) 37 (16)
Drug use 52 (2.4) 4 (0.42) 12 (1.8) 8 (2.6) 28 (12)
Homelessness 42 (2.0) 3 (0.32) 12 (1.8) 10 (3.3) 17 (7.5)
Previous TB 118 (5.5) 34 (3.6) 38 (5.8) 16 (5.3) 30 (13)
Clinically complex 320 (15) 10 (1.1) 92 (14) 105 (35) 113 (50)
Mental illness 68 (3.2) 3 (0.32) 23 (3.5) 17 (5.6) 25 (11)
Hard-to-reach group 50 (2.3) 2 (0.21) 12 (1.8) 11 (3.6) 25 (11)
Poor adherence 106 (5.0) 4 (0.42) 20 (3.0) 17 (5.6) 65 (29)
Incarceration 58 (2.7) 9 (1.0) 18 (2.7) 10 (3.3) 21 (9.3)
Gipsy traveller 3 (0.14) 0 0 0 3 (1.3)
Child protection issues 15 (0.70) 0 2 (0.30) 3 (1.0) 10 (4.4)
Language barrier 405 (19) 27 (2.9) 224 (34) 96 (32) 58 (26)
Contacts identified§ NA
Contacts 10 019 (100) 3 998 (40) 3 223 (32) 1 526 (15) 1 272 (13)
Child contacts 3 266 (100) 1 362 (42) 1 123 (34) 475 (15) 306 (9)
Contacts identified per patient, mean 6 SD¶ ,0.001
Contacts 4.7 6 3.8 4.2 6 3.5 4.9 6 3.8 5.0 6 4.3 5.6 6 4.2 0.02
Child contacts 1.5 6 1.9 1.4 6 1.7 1.7 6 2.0 1.6 6 2.1 1.3 6 1.9
Contacts assessed and diagnosed with LTBI#
Assessed 9 201 (92) 3 711 (93) 2 985 (93) 1 368 (90) 1 137 (89) ,0.001
Diagnosed LTBI 690 (7.5) 217 (5.7) 224 (7.4) 132 (8.1) 117 (10) ,0.001
Started LTBI treatment 611 (89) 194 (89) 195 (87) 120 (91) 96 (82) ,0.001
Completed LTBI treatment 517 (85) 171 (88) 166 (85) 103 (86) 77 (80) 0.03
Child contacts assessed and diagnosed with LTBI
Assessed 3 171 (97) 1 329 (98) 1 084 (97) 461 (97) 297 (96) 0.06
Diagnosed LTBI 277 (8.7) 68 (5.0) 108 (9.6) 58 (12) 43 (14) ,0.001
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ECM-0: 6.8%, 95%CI 5.5–7.9; P, 0.001; Figure 1).
Comparing ECM-3 with ECM-0, NNS to identify
one case of active TB disease was respectively 24 vs.
91, to identify one case of LTBI was 10 vs. 19 and to
identify one positive screening outcome was 7 vs. 15
(Figure 1).
Multivariable logistic regression showed that spu-
tum smear positivity, higher ECM level or Black
Caribbean ethnicity of patients were independently
associated with their contacts’ risk of active TB disease
(smear-positive vs. smear-negative: OR 5.3, 95%CI
3.2–8.7; ECM-3 vs. ECM-0: OR 2.2, 95%CI 1.01–5.0;
Black Caribbean vs. White: OR 7.4, 95%CI 2.1–25;
Figure 2). Sputum smear positivity and Black Caribbe-
an origin of patients were also independently associat-
ed with their contacts’ risk of LTBI (smear-positive vs.
smear-negative: OR 5.3, 95%CI 3.8–7.3; and Black
Caribbean vs. White: OR 6.7, 95%CI 2.0–25).
DISCUSSION
A simple risk stratification score generated by the TB
multidisciplinary team at TBCA was implemented in
North West England to estimate the ECM need of TB
cases. Contacts of TB patients with a higher ECM
level—and therefore, greater clinical and social
complexity—and/or Black Caribbean ethnicity were
more likely to have LTBI and active TB disease.
Evaluation of the social and clinical risk factors of TB
patients and estimation of their ECM level can be
useful indicators of risk of a positive TB screening
outcome among their contacts. Such evaluation could
be used to prioritise contact tracing resources towards
high-risk households to potentially enhance the
effectiveness of TB prevention measures.
In high-income countries, ECM in high-risk TB
patients, including those who use drugs and/or are
homeless, has been shown to reduce poor adherence,
loss to follow-up and death.6.7 Our previous research
Table 2 (continued)
Total
n (%)
ECM 0
n (%)
ECM 1
n (%)
ECM 2
n (%)
ECM 3
n (%) P value*
Started LTBI treatment 270 (97) 67 (99) 103 (95) 58 (100) 42 (98) 0.8
Completed LTBI treatment 224 (83) 59 (88) 84 (82) 48 (83) 33 (79) 0.5
*v2 test for trend (dichotomous variables) or Pearson’s v2 test (other categorical variables) across ECM levels 0–3.
†v2 test for trend of White vs. non-White ethnic group across ECM levels 0–3.
‡ Each separate ECM variable had P , 0.001 on v2 test for trend across ECM levels 0–3.
§ Percentages indicate the proportion of contacts of patients at each ECM level.
¶ Analysis of variance was used to compare means of contacts identified per patient across ECM level.
# Percentage assessed¼proportion of identified contacts assessed; proportion diagnosed LTBI¼proportion of assessed contacts diagnosed with LTBI; proportion
started LTBI treatment¼ proportion of those diagnosed with LTBI who started LTBI treatment; proportion completed LTBI treatment¼ proportion of those who
started LTBI treatment who completed LTBI treatment.
ECM¼ enhanced case management; TB¼ tuberculosis; IQR¼ interquartile range; SD¼ standard deviation; LTBI¼ latent tuberculous infection.
Figure 2 Multivariable logistic regression of patients’ (n¼2139) characteristics and social/clinical
risk factors and their association with LTBI and active TB disease in their contacts. The model was
adjusted for clustering of contacts by the index patient. Due to a non-linear relationship between
patient age and risk of LTBI and active TB disease among contacts, a restricted cubic splines term
for age with 3 knots was included in the model. TB ¼ tuberculosis; LTBI ¼ latent tuberculous
infection; ECM¼ enhanced case management; OR¼ odds ratio; CI¼ confidence interval.
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from North West England has shown that patients
with higher ECM levels are more likely to have
adverse TB treatment outcomes, despite the mitigat-
ing effects of enhanced TB care.4
Our new findings suggest that not only may TBCA
and ECM be vital in identifying patients who require
additional support to achieve TB treatment success,
but that these can also be used to indirectly estimate
the needs of the close contacts of these patients. This
is important because contact tracing and provision of
preventive therapy are well-established, important
tools in TB prevention, and enhanced support is
required not only for high-risk TB patients but also
for their households.2,5
Multiple scoring systems have been developed to
estimate the risk of LTBI and active TB disease in the
close contacts of TB patients. In Taiwan, an eight-point
contact risk assessment scoring system was developed
and validated to identify child contacts at risk of
developing active TB disease.8 In Peru, social and
clinical risk factors such as body mass index, previous
TB, level of exposure, poverty, indoor air pollution and
ventilation were used to derive and validate a scoring
system to estimate the risk of developing TB disease in
adult contacts.9 In Uganda, a modified version of the
World Health Organization’s pragmatic screening
algorithm for the child (age ,16 years) contacts of
adult TB cases was used to identify children at high risk
of asymptomatic, subclinical TB disease.10
However, these risk scores all rely on individual-
level data on each contact’s risk factors, which are not
currently collected by England’s ETS system or the
North West’s regional TBCA. The results of our
analysis of ECM are the first to show that patients’
ECM risk stratification and other patient character-
istics, including ethnicity, can be applied to estimate
the risk of LTBI and active TB disease in their
household contacts.
Our study had several limitations. First, TBCA
mostly occurred following treatment initiation, and
variables contributing to ECM classification include
confounding factors such as patients having poor
adherence to anti-tuberculosis treatment or having
child contacts, both of which are known to be
associated with a higher risk of LTBI and active TB
disease.9 To overcome this limitation, we performed a
sensitivity analysis in which we excluded those patients
assigned ECM levels 1–3 with poor adherence to anti-
tuberculosis treatment or a child contact. The sensi-
tivity analysis was broadly consistent with the original
analysis and is shown in Figure 1. Second, the ETS and
TBCA data used for analysis were limited to patients
from North West England. Findings may thus not be
generalisable to other regions of England or world-
wide. Third, ETS and TBCA data concerning contacts
were limited to aggregate data because individual-level
data (e.g., sociodemographic variables, and screening
and LTBI preventive therapy outcomes of each
individual contact) were not recorded. The lack of
such contact data is a weakness of the current ETS and
TBCA system, and it will be important to consider
inclusion of more detailed (and individualised) TB
prevention and control activities in future iterations of
both as England and the United Kingdom progress
towards TB elimination. Fourth, we could not
elucidate whether the LTBI or active TB disease
identified in household contacts was attributable to
recent transmission of TB from the index case because
no longitudinal tuberculin skin test or interferon-
gamma release assay results were available and no
genotyping data used. Finally, the number of TB cases
with Black Caribbean ethnicity in the region was small
(n ¼ 11). Although statistically significant, the
association found between Black Caribbean ethnicity
and likelihood of LTBI or active TB disease therefore
has a high degree of uncertainty (reflected by the wide
CIs, seen in Figure 2) and should be interpreted with
caution. Further studies with a larger cohort of TB
cases are necessary to confirm this finding.
CONCLUSION
In North West England, the contacts of TB patients
with higher social and clinical complexity, measured
using a simple ECM evaluation or having Black
Caribbean ethnicity, had greater odds of LTBI and
active TB disease prevalence. These findings support
the role of TBCA and ECM evaluation in North West
England and can contribute to pragmatic prioritisa-
tion of the TB multidisciplinary workforce to reach
TB-affected households with the greatest need. As
England progresses towards the goal of TB elimina-
tion, such prioritisation could enhance the efficiency
of constrained TB prevention resources.11
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R E´ S U M E´
OB J E C T I F : Etudier l’association entre les facteurs de
risque sociaux et les risques d’infection tuberculeuse et
de maladie chez leurs contacts en Angleterre.
S CH E´MA : Ceci a e´te´ une e´tude de cohorte de tous les
cas de tuberculose (TB) du Nord-Ouest de l’Angleterre
diagnostique´s entre le 27 mars 2012 et le 28 juin 2016.
Les donne´es ont e´te´ recueillies a` partir du syste`me
national ame´liore´ de surveillance de la TB (ETS) et de la
revue de la cohorte du North West TB, au cours de
laquelle les facteurs de risque sociaux des cas de TB sont
e´value´s afin d’estimer leurs besoins de prise en charge
ame´liore´e des cas (ECM), d’ECM-0 (norme de soins) a`
ECM-3 (soutien social intensif).
R E´ S U LTAT S : Un total des 2139 cas et leurs 10 019
contacts ont re´pondu aux crite`res d’e´ligibilite´. Etre un
contact d’un patient avec une TB a` frottis positif, un
ECM e´leve´, ou eˆtre d’origine ethnique noire des Caraı¨bes
a e´te´ inde´pendamment associe´ a` des risques plus e´leve´s
de TB active (frottis positif contre frottis ne´gatif : OR
5,3 ; IC95% 3,2–8,7 ; ECM-3 contre ECM-0 : OR 2,2 ;
IC95% 1,01–5,0 ; ethnie noir des Caraı¨bes contre
blanche : OR 7,4 ; IC95% 2,1-25). Etre un contact
d’un patient atteint de TB a` frottis positif ou d’origine
noire des Caraı¨bes a e´galement e´te´ inde´pendamment
associe´ a` des risques plus e´leve´s d’infection TB (frottis
positif contre frottis ne´gatif : OR 5,3 ; IC95% 3,8–7,3 ;
et noir des Caraı¨bes contre blanc : OR 6,7 ; IC95% 2,0–
25).
CONC LU S I ON : La complexite´ sociale et ethnique des
patients a e´te´ associe´e a` l’infection TB et a` la TB maladie
parmi leurs contacts.
R E S UM E N
O B J E T I V O: Investigar la asociacio´n entre los
determinantes sociales de los pacientes y el riesgo de
sus contactos de contraer la infeccio´n tuberculosa y la
enfermedad activa en Inglaterra.
M E´ TODO: Fue este un estudio de cohortes de todos los
casos de tuberculosis (TB) de la Regio´n del Noroeste de
la Inglaterra diagnosticados del 27 de marzo del 2012 al
28 de junio del 2016. Se obtuvieron datos a partir del
sistema nacional de vigilancia reforzada de la TB (ETS)
y del examen de la cohorte de TB de la Regio´n del
Noroeste, durante el cual se evaluaron los factores de
riesgo sociales de los casos de TB, con el fin de estimar
las necesidades para la iniciativa de reforzar la gestio´n de
casos (ECM), desde el nivel ECM 0 (normas asistenciales
corrientes) hasta el nivel ECM 3 (apoyo social
intensivo).
R E SU LTADOS: Cumplieron los criterios de seleccio´n
2139 casos y sus 10 019 contactos. Los factores
asociados de manera independiente con una mayor
probabilidad de padecer TB activa fueron el hecho de ser
contacto de un paciente tuberculoso con baciloscopia
positiva (baciloscopia positiva contra baciloscopia
negativa: OR 5,3; IC95% 3,2–8,7); asignado a un
ECM de alto nivel (ECM 3 contra ECM 0: OR 2,2;
IC95% 1,01–5,0); o perteneciente a la etnia
afrocariben˜a (afrocariben˜a contra blanca: OR 7,4;
IC95% 2,1–25). Se asociaron con una mayor
probabilidad de contraer la infeccio´n tuberculosa el
hecho de ser contacto de un paciente tuberculoso con
baciloscopia positiva (baciloscopia positiva contra
baciloscopia negativa: OR 5,3; IC95% 3,8–7,3); o de
origen afrocariben˜o (etnia afrocariben˜a contra blanca:
OR 6,7; IC95% 2,0–25).
CONC LU S I ON E S: La complejidad de la situacio´n social
de los pacientes y su etnia se asociaron con la aparicio´n
de infeccio´n tuberculosa y enfermedad activa en sus
contactos.
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